A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Kyowa Kirin Co., Ltd.
Kyowa Kirin Co., Ltd.
Dren Bio
Merck Sharp & Dohme LLC
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)
Eastern Cooperative Oncology Group
Merck Sharp & Dohme LLC
University of California, Davis
University Health Network, Toronto
Ossium Health, Inc.
Dana-Farber Cancer Institute
Essen Biotech
St. Jude Children's Research Hospital